Triccas JA - Search Results

1

Affordable SARS-CoV-2 protein vaccines for the pandemic endgame.

Triccas JA, Kint J, Wurm FM. Triccas JA, et al. NPJ Vaccines. 2022 Aug 2;7(1):89. doi: 10.1038/s41541-022-00507-8. NPJ Vaccines. 2022. PMID: 35918346 Free PMC article. No abstract available.

2

Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis.

Counoupas C, Ferrell KC, Ashhurst A, Bhattacharyya ND, Nagalingam G, Stewart EL, Feng CG, Petrovsky N, Britton WJ, Triccas JA. Counoupas C, et al. Among authors: triccas ja. NPJ Vaccines. 2020 Nov 12;5(1):105. doi: 10.1038/s41541-020-00255-7. NPJ Vaccines. 2020. PMID: 33298977 Free PMC article.

3

A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection.

Counoupas C, Johansen MD, Stella AO, Nguyen DH, Ferguson AL, Aggarwal A, Bhattacharyya ND, Grey A, Hutchings O, Patel K, Siddiquee R, Stewart EL, Feng CG, Hansbro NG, Palendira U, Steain MC, Saunders BM, Low JKK, Mackay JP, Kelleher AD, Britton WJ, Turville SG, Hansbro PM, Triccas JA. Counoupas C, et al. Among authors: triccas ja. NPJ Vaccines. 2021 Nov 30;6(1):143. doi: 10.1038/s41541-021-00406-4. NPJ Vaccines. 2021. PMID: 34848711 Free PMC article.

4

High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens.

Counoupas C, Pino P, Stella AO, Ashley C, Lukeman H, Bhattacharyya ND, Tada T, Anchisi S, Metayer C, Martinis J, Aggarwal A, Dcosta BM, Britton WJ, Kint J, Wurm MJ, Landau NR, Steain M, Turville SG, Wurm FM, David SA, Triccas JA. Counoupas C, et al. Among authors: triccas ja. Microbiol Spectr. 2022 Feb 23;10(1):e0169521. doi: 10.1128/spectrum.01695-21. Epub 2022 Feb 16. Microbiol Spectr. 2022. PMID: 35171046 Free PMC article.

5

Lung IL-17A-Producing CD4⁺ T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis Vaccines.

Stewart EL, Counoupas C, Quan DH, Wang T, Petrovsky N, Britton WJ, Triccas JA. Stewart EL, et al. Among authors: triccas ja. Vaccines (Basel). 2024 Jan 26;12(2):128. doi: 10.3390/vaccines12020128. Vaccines (Basel). 2024. PMID: 38400112 Free PMC article.

6

Mycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice.

Counoupas C, Pinto R, Nagalingam G, Hill-Cawthorne GA, Feng CG, Britton WJ, Triccas JA. Counoupas C, et al. Among authors: triccas ja. NPJ Vaccines. 2016 Sep 15;1:16012. doi: 10.1038/npjvaccines.2016.12. eCollection 2016. NPJ Vaccines. 2016. PMID: 29263854 Free PMC article.

7

Characterization of the Protective Immune Responses Conferred by Recombinant BCG Overexpressing Components of Mycobacterium tuberculosis Sec Protein Export System.

Nisa A, Counoupas C, Pinto R, Britton WJ, Triccas JA. Nisa A, et al. Among authors: triccas ja. Vaccines (Basel). 2022 Jun 14;10(6):945. doi: 10.3390/vaccines10060945. Vaccines (Basel). 2022. PMID: 35746553 Free PMC article.

8

Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis?

Warner S, Blaxland A, Counoupas C, Verstraete J, Zampoli M, Marais BJ, Fitzgerald DA, Robinson PD, Triccas JA. Warner S, et al. Among authors: triccas ja. Vaccines (Basel). 2023 Aug 1;11(8):1313. doi: 10.3390/vaccines11081313. Vaccines (Basel). 2023. PMID: 37631881 Free PMC article.

9

CXCR3 Provides a Competitive Advantage for Retention of Mycobacterium tuberculosis-Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine.

Armitage E, Quan D, Flórido M, Palendira U, Triccas JA, Britton WJ. Armitage E, et al. Among authors: triccas ja. Vaccines (Basel). 2023 Sep 29;11(10):1549. doi: 10.3390/vaccines11101549. Vaccines (Basel). 2023. PMID: 37896952 Free PMC article.

10

Mycobacterium tuberculosis Deficient in PdtaS Cytosolic Histidine Kinase Displays Attenuated Growth and Affords Protective Efficacy against Aerosol M. tuberculosis Infection in Mice.

Prendergast KA, Nagalingam G, West NP, Triccas JA. Prendergast KA, et al. Among authors: triccas ja. Vaccines (Basel). 2024 Jan 2;12(1):50. doi: 10.3390/vaccines12010050. Vaccines (Basel). 2024. PMID: 38250863 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page